Scilex Holding Co (SCLXW)
2025-06-30 | ||||
---|---|---|---|---|
Net revenue | 9,896 | |||
Selling, general and administrative | 19,841 | |||
Research and development | 6,187 | |||
Cost of revenue | 3,272 | |||
Intangible amortization | 1,008 | |||
Intangible amortization | 1,000 | |||
Legal settlements | -95 | |||
Total net operating costs and expenses | 30,403 | |||
Loss from operations | -20,507 | |||
Interest expense, net | 2,682 | |||
Loss on foreign currency exchange | -99 | |||
Loss on derivative liability | -12,375 | |||
Change in fair value of debt and liability instruments | 8,366 | |||
Total other expense | -23,522 | |||
Loss before income taxes | -44,029 | |||
Income tax expense | 19 | |||
Net loss | -44,048 | |||
Net loss attributable to noncontrolling interests | -1,740 | |||
Deemed dividend | -43,753 | |||
Net loss attributable to common stockholders | -86,061 | |||
Loss per share, basic | -7.42 | |||
Loss per share, diluted | -7.42 | |||
Weighted average number of shares - basic | 11,595 | |||
Weighted average number of shares, diluted | 11,595 |